Nexalis Therapeutics Limited has released a press release.
Pause in Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- CEO appointment
- Reinstatement to Official Quotation
- Private Placement and Market update
- Voluntary Suspension
- Private Placement Successfully Completed to raise $300,000
Later from Nexalis Therapeutics
- Quarter 3 Update
- $720,500 Private Placement
- Non-renounceable rights issue
- Rights Issue Offer Document
- Placement of Rights Issue Shortfall
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics